Monoamine Oxidase Deficiency Foundation
Monoamine Oxidase Deficiency Foundattion was established in 2022 to increase awareness of and fund research for a regenerative medicine treatment for all Monoamine Oxidase Deficiencies. We are currently engaged in gene replacemeent therapy research but are open to other avenues of treatment, specifically stem cell therapy, RNA therapies, and small molecules.
